Living With Fibromyalgia: Triggers,Subgroups, and a Cognitive-Behavioral and Interactive Technology-Based Intervention

This study has been completed.
Sponsor:
Collaborators:
SHRS Research Development Fund
U.S. Department of Education
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00222690
First received: September 14, 2005
Last updated: May 26, 2006
Last verified: September 2005
  Purpose

The purpose of this study is to conduct semi-structured qualitative interviews to examine the personal experiences of women living with fibromyalgia. The specific aims of this study are to identify clinically relevant “triggers” of fibromyalgia symptoms and examine their impact on activity limitations and participation restrictions.


Condition
Fibromyalgia

Study Type: Observational
Study Design: Additional Descriptors: Psychosocial
Allocation: Random Sample
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Living With Fibromyalgia (FM): Triggers,Clinical Subgroups, and the Effects Of A Self-Monitored Cognitive-Behavioral and Interactive Technology-Based Intervention on Clinical Subgroups

Resource links provided by NLM:


Further study details as provided by University of Pittsburgh:

Estimated Enrollment: 30
Study Start Date: June 2005
Estimated Study Completion Date: June 2006
Detailed Description:

Fibromyalgia (FM) may currently be the most common rheumatic diagnosis of rheumatologists among their female patients, with 15-20% of all new rheumatology referrals meeting the 1990 American College of Rheumatology (ACR) diagnosis criteria for fibromyalgia. People with fibromyalgia live through widespread musculoskeletal chronic pain, fatigue, psychological distress, and exhibit diminished physical performance due in part to the cycle of pain that adversely affect their activity participation and overall well-being.

The purpose of this prospective mixed methods study is to conduct semi-structured qualitative interviews using ethnographic techniques to examine the personal experiences of women living with fibromyalgia. The specific aims of this study are to identify clinically relevant “triggers” of fibromyalgia symptoms and examine their impact on activity limitations and participation restrictions.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

(1)At least 18 years of age; (2) meet the American College of Rheumatology (ACR) criteria for FM as diagnosed by a physician; (3) have been diagnosed with FM at least 1 year prior to admission to the study; (4) have sufficient vision, based on a functional vision test (i.e., read newsprint) to operate a computer program; (5) speak English; and (6) have a private telephone line.

Exclusion Criteria:

(1)Living beyond a 40-mile radius from the Oakland campus of the University of Pittsburgh. (2)Disability in everyday tasks related to a diagnosis other than FM (e.g., stroke, Parkinson disease) will also be grounds for exclusion.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00222690

Locations
United States, Pennsylvania
University of Pittsburgh - Department of Occupational Therapy
Pittsburgh, Pennsylvania, United States, 15260
Sponsors and Collaborators
University of Pittsburgh
SHRS Research Development Fund
U.S. Department of Education
Investigators
Principal Investigator: Hazel L Breland, PhD University of Pittsburgh
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00222690     History of Changes
Other Study ID Numbers: 0505178
Study First Received: September 14, 2005
Last Updated: May 26, 2006
Health Authority: United States: Food and Drug Administration

Keywords provided by University of Pittsburgh:
qualitative interview
symptom triggers
activity and participation

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on May 19, 2013